Mezagitamab Uses, Dosage, Side Effects and more
Mezagitamab is under investigation in clinical trial NCT04278924 (Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Persistent/chronic Primary Immune Thrombocytopenia).
| Trade Name | Mezagitamab |
| Generic | Mezagitamab |
| Mezagitamab Other Names | Mezagitamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
